This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Oct;1(7):881-3.

doi: 10.1001/jamaoncol.2015.2607.

Rethinking the Standard for Ductal Carcinoma In Situ Treatment

Laura Esserman¹, Christina Yau¹

Affiliations

PMID: 26291410
DOI: 10.1001/jamaoncol.2015.2607

Editorial

Rethinking the Standard for Ductal Carcinoma In Situ Treatment

Laura Esserman et al. JAMA Oncol. 2015 Oct.

. 2015 Oct;1(7):881-3.

doi: 10.1001/jamaoncol.2015.2607.

Authors

Laura Esserman¹, Christina Yau¹

Affiliation

¹ Department of Surgery, University of California, San Francisco, California.

PMID: 26291410
DOI: 10.1001/jamaoncol.2015.2607

No abstract available

PubMed Disclaimer

Comment in

Pathologic Abnormalities Behind Ductal Carcinoma In Situ Terminology.
Foucar E. Foucar E. JAMA Oncol. 2016 Mar;2(3):394-5. doi: 10.1001/jamaoncol.2015.4843. JAMA Oncol. 2016. PMID: 26967175 No abstract available.
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.
Espina V, Williams JP, Liotta LA. Espina V, et al. JAMA Oncol. 2016 Mar;2(3):395. doi: 10.1001/jamaoncol.2015.4846. JAMA Oncol. 2016. PMID: 26967176 No abstract available.
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-Reply.
Esserman L, Yau C. Esserman L, et al. JAMA Oncol. 2016 Mar;2(3):395-6. doi: 10.1001/jamaoncol.2015.4840. JAMA Oncol. 2016. PMID: 26967177 No abstract available.

Comment on

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Narod SA, et al. JAMA Oncol. 2015 Oct;1(7):888-96. doi: 10.1001/jamaoncol.2015.2510. JAMA Oncol. 2015. PMID: 26291673

Similar articles

Effects of Standard Treatments for Ductal Carcinoma In Situ-Making Informed Choices.
Fallowfield L, Francis A, Thompson AM. Fallowfield L, et al. JAMA Oncol. 2016 Mar;2(3):396-7. doi: 10.1001/jamaoncol.2015.4857. JAMA Oncol. 2016. PMID: 26967179 No abstract available.
Treatment Recommendations for Patients With a Diagnosis of Ductal Carcinoma In Situ.
Keiding N, Opdahl S, Holmberg L. Keiding N, et al. JAMA Oncol. 2016 Mar;2(3):398. doi: 10.1001/jamaoncol.2015.4863. JAMA Oncol. 2016. PMID: 26967181 No abstract available.
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.
Boyages J, Stuart K, Shah C. Boyages J, et al. JAMA Oncol. 2016 Mar;2(3):399-400. doi: 10.1001/jamaoncol.2015.4875. JAMA Oncol. 2016. PMID: 26967184 No abstract available.
Breast cancer: non-metastatic.
Dixon JM, Gregory K, Johnston S, Rodger A. Dixon JM, et al. Clin Evid. 2002 Dec;(8):1811-39. Clin Evid. 2002. Update in: Clin Evid. 2003 Jun;(9):1940-70. PMID: 12603971 Updated. Review. No abstract available.
Breast cancer: non-metastatic.
Dixon JM, Gregory K, Johnston S, Rodger A. Dixon JM, et al. Clin Evid. 2002 Jun;(7):1603-30. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):1811-39. PMID: 12230775 Updated. Review. No abstract available.

See all similar articles

Cited by

Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics.
Zhang H, Zhao T, Ding J, Wang Z, Cao N, Zhang S, Xie K, Sun J, Gao L, Li X, Ni X. Zhang H, et al. Biomed Eng Online. 2024 Nov 21;23(1):117. doi: 10.1186/s12938-024-01315-y. Biomed Eng Online. 2024. PMID: 39574126 Free PMC article.
Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus-Faced Manner.
Suba Z. Suba Z. Curr Oncol. 2024 Aug 24;31(9):4885-4907. doi: 10.3390/curroncol31090362. Curr Oncol. 2024. PMID: 39329990 Free PMC article. Review.
Survival outcomes after omission of surgery for ductal carcinoma in situ.
Poli EC, Dong W, Shaitelman SF, Tamirisa N, Shen Y, Bedrosian I. Poli EC, et al. NPJ Breast Cancer. 2024 Sep 20;10(1):82. doi: 10.1038/s41523-024-00689-5. NPJ Breast Cancer. 2024. PMID: 39304662 Free PMC article.
Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma in situ.
Zhu M, Kuang Y, Jiang Z, Liu J, Zhang H, Zhao H, Luo H, Chen Y, Peng Y. Zhu M, et al. Gland Surg. 2024 Apr 29;13(4):512-527. doi: 10.21037/gs-23-417. Epub 2024 Apr 11. Gland Surg. 2024. PMID: 38720675 Free PMC article.
Ultrafast MRI and T1 and T2 Radiomics for Predicting Invasive Components in Ductal Carcinoma in Situ Diagnosed With Percutaneous Needle Biopsy.
Kim MY, Yoen H, Ji H, Park SJ, Kim SM, Han W, Cho N. Kim MY, et al. Korean J Radiol. 2023 Dec;24(12):1190-1199. doi: 10.3348/kjr.2023.0208. Korean J Radiol. 2023. PMID: 38016679 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information